Quarterly report pursuant to Section 13 or 15(d)

Supplemental Disclosure of Cash Flow Information (Tables)

v3.21.2
Supplemental Disclosure of Cash Flow Information (Tables)
6 Months Ended
Jun. 30, 2021
Supplemental Cash Flow Elements [Abstract]  
Schedule of Supplemental Disclosure of Cash Flow Information

 

    2021     2020  
    Six Months Ended June 30,  
    2021     2020  
Cash paid for interest   $ -     $ 9,455  
Cash paid for income taxes   $ 281,025     $ -  
                 
Non-cash investing and financing activities:                
Preferred stock of VisualMED received from the sale of HTS and AMSG   $ 8,500,000     $ -  
Net liabilities of HTS and AMSG transferred to VisualMED     2,227,152       -  
Series I-2 Preferred Stock converted into common stock     -       25,000  
Exchange of Series K Preferred Stock for Series L Preferred Stock     -       (2,500 )
Issuance of Series L Preferred Stock     -       2,500  
Issuance of Series M Preferred Stock in exchange for related party loans and accrued interest     -       22,000,000  
Loans and accrued interest exchanged for Series M Preferred Stock     -       18,849,632  
Deemed dividend from exchange of loans and accrued interest for Series M Preferred Stock     -       3,150,368  
Series M Preferred Stock converted into common stock     619,650       -  
Series N Preferred Stock converted into common stock     13,065,527       -  
Deemed dividends for trigger of down round provisions     149,611,479       -  
Original issue discounts on debt     27,630       63,695